Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment (unspecified eye)
ICD-10 E09.3549 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment (unspecified eye).
E09.3549 refers to diabetes mellitus that has been induced by drugs or chemicals, leading to significant complications including proliferative diabetic retinopathy. This condition is characterized by the growth of abnormal blood vessels in the retina, which can lead to vision loss. In this specific case, the patient experiences both traction retinal detachment and rhegmatogenous retinal detachment, indicating a severe progression of the disease. The unspecified eye designation indicates that the documentation does not specify which eye is affected. Management of this condition requires careful monitoring of blood glucose levels, often through HbA1c testing, to assess long-term glucose control. Insulin therapy may be necessary to manage blood sugar levels effectively, especially in cases where oral hypoglycemics are ineffective due to the drug-induced nature of the diabetes. The presence of diabetic retinopathy and retinal detachment complicates the clinical picture, necessitating a multidisciplinary approach for treatment and management.
Detailed history of diabetes management, including medication history and HbA1c levels.
Patients with drug-induced diabetes requiring insulin therapy and monitoring for complications.
Ensure accurate documentation of the drug responsible for diabetes and its management.
Comprehensive eye examination reports, including details on retinal detachment and treatment plans.
Patients presenting with vision changes due to diabetic retinopathy and retinal detachment.
Document the type of retinal detachment and any surgical interventions performed.
Used for treating proliferative diabetic retinopathy.
Document the extent of retinopathy and treatment plan.
Ophthalmology should provide detailed reports on the procedure.
Specifying the eye affected is crucial for treatment planning and understanding the severity of the condition, as management may differ based on whether one or both eyes are involved.
